A New Future for DNA

By KIM BELLARD As a DNA-based creature myself, I’m always fascinated by DNA’s remarkable capabilities. Not just all the ways that life has found to use it, but our ability to find new ways to take advantage of them. I’ve written about DNA as a storage medium, as a neural network, as a computer, in…

Read More

Treatment Tops Housing in Trump Homeless Policy

Is homelessness a mental health and addiction crisis, or is it driven by an affordable housing crisis? That question underpins the debate among policymakers and politicians struggling to move people off the streets faster than they become homeless.  Researchers say housing is the most important intervention to end homelessness, and now a report from the…

Read More

BioMarin’s $270M Inozyme Acquisition Brings Drug That Could Become First for a Rare Disease

Inozyme Pharma’s main asset is in pivotal testing in children who have a rare enzyme deficiency that affects bones and blood vessels. BioMarin Pharmaceutical, already well established in enzyme replacement, said it will use its experience and infrastructure to grow the market for this product, potentially for several indications. The post BioMarin’s $270M Inozyme Acquisition…

Read More

‘Demon Copperhead’ Author Lays Foundation for Women in Appalachia To Beat Addiction

PENNINGTON GAP, Va. — On a Saturday evening in June, people of this rural region gathered at the historic Lee Theatre to celebrate the founding of Higher Ground Women’s Recovery Residence. Author Barbara Kingsolver opened the facility in January with royalties from her Pulitzer Prize-winning novel, “Demon Copperhead,” whose plot revolves around Appalachia’s opioid crisis….

Read More

Cartography Bio Corrals $67M to Bring Targeted Colorectal Cancer Drug Into the Clinic

Pfizer Ventures led the Series B financing of Cartography Biosciences, whose lead program addresses a promising target for colorectal cancer. The startup’s drugs come from platform technologies that analyze data from healthy cells and cancer cells to identify cancer-specific targets. The post Cartography Bio Corrals $67M to Bring Targeted Colorectal Cancer Drug Into the Clinic…

Read More